Core Viewpoint - The company Brainstorm Cell Therapeutics (06681) has seen a stock increase of over 13% following the announcement of a strategic partnership with Silk Road Technology Co., Ltd. to expand its digital therapy products in Malaysia and Southeast Asia [1] Group 1 - The strategic cooperation agreement aims to localize, promote, and transform research related to cognitive impairment digital therapy products in the Malaysian and Southeast Asian markets [1] - The board believes this partnership marks the company's official entry into the Malaysian market, further expanding its Southeast Asian business network [1] - The collaboration is expected to leverage the company's validated digital therapy experience and technology from the Chinese market to enhance its brand influence and business coverage internationally [1]
港股异动 | 脑动极光-B(06681)涨超13% 与丝路之舟订立战略合作协议 进入马来西亚市场